Margarita López Trascasa
Margarita López Trascasa
Profesora de Inmunología
Verifierad e-postadress på uam.es
Titel
Citeras av
Citeras av
År
The human complement factor H: functional roles, genetic variations and disease associations
SR de Córdoba, J Esparza-Gordillo, EG de Jorge, M Lopez-Trascasa, ...
Molecular immunology 41 (4), 355-367, 2004
6492004
Gain-of-function mutations in complement factor B are associated with atypical hemolytic uremic syndrome
EG de Jorge, CL Harris, J Esparza-Gordillo, L Carreras, EA Arranz, ...
Proceedings of the National Academy of Sciences 104 (1), 240-245, 2007
4602007
Clustering of missense mutations in the C-terminal region of factor H in atypical hemolytic uremic syndrome
D Pérez-Caballero, C González-Rubio, ME Gallardo, M Vera, ...
The American Journal of Human Genetics 68 (2), 478-484, 2001
3192001
Predisposition to atypical hemolytic uremic syndrome involves the concurrence of different susceptibility alleles in the regulators of complement activation gene cluster in 1q32
J Esparza-Gordillo, EG Jorge, A Buil, LC Berges, M Lopez-Trascasa, ...
Human Molecular Genetics 14 (5), 703-712, 2005
2912005
Structural and functional characterization of factor H mutations associated with atypical hemolytic uremic syndrome
P Sánchez-Corral, D Pérez-Caballero, O Huarte, AM Simckes, ...
The American Journal of Human Genetics 71 (6), 1285-1295, 2002
2422002
Hereditary angioedema due to C1 inhibitor deficiency: patient registry and approach to the prevalence in Spain
O Roche, A Blanch, T Caballero, N Sastre, D Callejo, M López-Trascasa
Annals of Allergy, Asthma & Immunology 94 (4), 498-503, 2005
2322005
Human C3 mutation reveals a mechanism of dense deposit disease pathogenesis and provides insights into complement activation and regulation
R Martínez-Barricarte, M Heurich, F Valdes-Cañedo, E Vazquez-Martul, ...
The Journal of clinical investigation 120 (10), 3702-3712, 2010
2192010
Consensus statement on the diagnosis, management, and treatment of Angiodema mediated by Bradykinin. Part I. Classification, epidemiology, pathophysiology, genetics, clinical …
T Caballero, ML Baeza, R Cabañas, A Campos, S Cimbollek, ...
Journal of Investigational Allergology and Clinical Immunology, 2011
205*2011
Characterization of complement factor H–related (CFHR) proteins in plasma reveals novel genetic variations of CFHR1 associated with atypical hemolytic uremic syndrome
C Abarrategui-Garrido, R Martínez-Barricarte, M López-Trascasa, ...
Blood 114 (19), 4261-4271, 2009
2012009
High prevalence of anti-C1q antibodies in biopsy-proven active lupus nephritis
M Trendelenburg, M Lopez-Trascasa, E Potlukova, S Moll, S Regenass, ...
Nephrology Dialysis Transplantation 21 (11), 3115-3121, 2006
2002006
High prevalence of anti-C1q antibodies in biopsy-proven active lupus nephritis
M Trendelenburg, M Lopez-Trascasa, E Potlukova, S Moll, S Regenass, ...
Nephrology Dialysis Transplantation 21 (11), 3115-3121, 2006
2002006
Functional analysis in serum from atypical Hemolytic Uremic Syndrome patients reveals impaired protection of host cells associated with mutations in factor H
P Sánchez-Corral, C Gonzalez-Rubio, SR de Córdoba, ...
Molecular immunology 41 (1), 81-84, 2004
1872004
The interactive factor h–atypical hemolytic uremic syndrome mutation database and website: update and integration of membrane cofactor protein and factor I mutations with …
RE Saunders, C Abarrategui‐Garrido, V Frémeaux‐Bacchi, ...
Human mutation 28 (3), 222-234, 2007
1772007
IgA glomerulonephritis (Berger's disease): evidence of high serum levels of polymeric IgA.
ML Trascasa, J Egido, J Sancho, L Hernando
Clinical and experimental immunology 42 (2), 247, 1980
1471980
Consensus statement on the diagnosis, management, and treatment of Angiodema mediated by Bradykinin. Part I. Classification, epidemiology, pathophysiology, genetics, clinical …
T Caballero, ML Baeza, R Cabañas, A Campos, S Cimbollek, ...
Journal of Investigational Allergology and Clinical Immunology, 2011
1452011
Insights into hemolytic uremic syndrome: segregation of three independent predisposition factors in a large, multiple affected pedigree
J Esparza-Gordillo, EG de Jorge, CA Garrido, L Carreras, ...
Molecular immunology 43 (11), 1769-1775, 2006
1342006
Consensus statement on the diagnosis, management, and treatment of angioedema mediated by Bradykinin. Part. II: treatment, follow-up, and special situations
T Caballero, ML Baeza, R Cabañas, A Campos, S Cimbollek, ...
Journal of Investigational Allergology and Clinical Immunology, 2011
1132011
Metallopeptidase activities in hereditary angioedema: effect of androgen prophylaxis on plasma aminopeptidase P
C Drouet, A Désormeaux, J Robillard, D Ponard, L Bouillet, L Martin, ...
Journal of allergy and clinical immunology 121 (2), 429-433, 2008
1052008
Cellular adhesion mediated by factor J, a complement inhibitor: evidence for nucleolin involvement
S Larrucea, C González-Rubio, R Cambronero, B Ballou, P Bonay, ...
Journal of Biological Chemistry 273 (48), 31718-31725, 1998
911998
Hereditary angioedema: The mutation spectrum of SERPING1/C1NH in a large Spanish cohort
O Roche, A Blanch, C Duponchel, G Fontán, M Tosi, M López‐Trascasa
Human mutation 26 (2), 135-144, 2005
822005
Systemet kan inte utföra åtgärden just nu. Försök igen senare.
Artiklar 1–20